Investors & Media

Investors & Media

Welcome to our investor page

We aspire to individualize cancer medicine

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To translate this idea into reality, we have combined ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and beyond. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine.


Stock Quote

Feb 19, 2020 /

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events

February 25 - February 27, 2020

9th Annual SVB Leerink Global Healthcare Conference

New York, NY

March 2 - March 4, 2020

40th Annual Cowen Health Care Conference

Boston, MA

March 3 - March 4, 2020

Credit Suisse 2020 Global Healthcare Conference

London, UK

Upcoming events (more)

Press Releases

3 February 2020

BioNTech Announces Commencement of Public Offering of American Depositary Share..

16 January 2020

BioNTech to acquire Neon to strengthen global leadership position in T cell the..

13 January 2020

BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Cont..

Press releases (more)